Neptune Technologies & Bioressources

Another under-$10 name that's quickly moving within range of triggering a major breakout trade is Neptune Technologies & Bioressources ( NEPT), which researches, develops and commercialises worldwide, natural marine-derived health products with clinically proven human health benefits. This stock is off to a hot start in 2013, with shares up notably by 35%.

If you take a look at the chart for Neptune Technologies & Bioressources, you'll notice that this stock has been trending sideways in a consolidation pattern for the last four months, with shares moving between $2.30 on the downside and $2.95 on the upside. Shares of NPET have just started to bounce right off its 50-day moving average of $2.56 and it's now quickly moving within range of breaking out above the upper end of its sideways chart pattern.

Market players should now look for long-biased trades in NEPT if it manages to break out above some near-term overhead resistance levels at $2.75 to $2.95 a share and then once it clears more resistance at $3.03 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 221,979 shares. If that breakout triggers soon, then NEPT will set up to re-test or possibly take out its next major overhead resistance levels at its 200-day of $3.29 to around $4 a share. Any high-volume move above $4 could then send NEPT towards its next major resistance levels at $4.75 to $5 a share.

Traders can look to buy NEPT off weakness to anticipate that breakout and simply use a stop that sits just its 50-day at $2.56 a share or below some more key near-term support levels at $2.40 to $2.30 a share. One can also buy NEPT off strength once it clears those breakout levels with volume and then simply use a stop just below its 50-day at $2.56 a share.

If you liked this article you might like

Drug Win for Depomed Could Be Hurdle for Starboard

Arbor and Purdue Seen as Likely Bidders for DepoMed

More Rare Disease Dealmaking to Follow Horizon's Raptor Deal

Fed Dove Brainard Pushes Stocks Into Rally Mode

Closing Bell: Fed's Brainard Cautions 'Prudence'; U.S. Stocks Soar